THE TUMOR SUPPRESSOR PML MEDIATES EVEROLIMUS-INDUCED CHANGES OF THE HCV REPLICATION ACTIVITY

被引：0
|
作者：
Frey, A. [1 ]
Ecker, E. -M. [1 ]
Piras-Straub, K. [1 ,2 ]
Walker, A. [3 ]
Hofmann, T. [4 ]
Gerken, G. [1 ]
Herzer, K. [1 ,2 ]
机构：
[1] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany
[2] Univ Hosp Essen, Dept Gen Viszeral & Transplantat Surg, Essen, Germany
[3] Univ Hosp Dusseldorf, Dept Virol, Dusseldorf, Germany
[4] German Canc Res Ctr, Heidelberg, Germany
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30896-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0693
引用
收藏
页码：S582 / S582
页数：1
相关论文
共 50 条
  • [1] Everolimus-Induced Pneumonitis In A Patient With Metastatic Carcinoid Tumor
    Hatem, N. Abi
    Sawaya, N.
    Lopez, R.
    Shah, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [2] PML tumor suppressor protein is required for HCV production
    Kuroki, Misao
    Ariumi, Yasuo
    Hijikata, Makoto
    Ikeda, Masanori
    Dansako, Hiromichi
    Wakita, Takaji
    Shimotohno, Kunitada
    Kato, Nobuyuki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 430 (02) : 592 - 597
  • [3] Everolimus-Induced Hematologic Changes in Patients With Metastatic Breast Cancer
    Chen, Amy
    Chen, Li
    Al-Qaisi, Abeer
    Romond, Edward
    Awasthi, Mukta
    Kadamyan-Melkumyan, Vera
    Massarweh, Suleiman
    CLINICAL BREAST CANCER, 2015, 15 (01) : 48 - 53
  • [4] Everolimus-Induced Transaminitis in the Setting of Stage IV Carcinoid Tumor With Liver Metastasis
    Nehme, Christian
    Ghazaleh, Sami
    Ghanim, Marcel
    Nesheiwat, Zeid
    Awad, Mohammed
    Khader, Yasmin
    Nawras, Ali
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1371 - S1371
  • [5] CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor
    Scaglioni, P. P.
    Yung, T. M.
    Choi, S. C.
    Baldini, C.
    Konstantinidou, G.
    Pandolfi, P. P.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2008, 316 (1-2) : 149 - 154
  • [6] CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor
    P. P. Scaglioni
    T. M. Yung
    S. C. Choi
    C. Baldini
    G. Konstantinidou
    P. P. Pandolfi
    Molecular and Cellular Biochemistry, 2008, 316 : 149 - 154
  • [7] HCV replication activity is modified by mTor-inhibitors in vitro which is mediated by PML
    Frey, A.
    Ecker, E-M
    Piras-Straub, K.
    Walker, A.
    Hofmann, T.
    Gerken, G.
    Herzer, K.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 69 - 70
  • [8] CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor
    P. P. Scaglioni
    T. M. Yung
    S. Choi
    C. Baldini
    G. Konstantinidou
    P. P. Pandolfi
    Molecular and Cellular Biochemistry, 2009, 327 : 279 - 279
  • [9] Successful Everolimus Treatment in a Patient with Advanced Pancreatic Neuroendocrine Tumor Who Developed Everolimus-Induced Interstitial Lung Disease on Two Occasions: A Case Report
    Nakayama, Yusuke
    Ikeda, Masafumi
    Kojima, Motohiro
    Goto, Koichi
    Hara, Miyuki
    Okuyama, Hiroyuki
    Takahashi, Hideaki
    Ohno, Izumi
    Shimizu, Satoshi
    Mitsunaga, Shuichi
    Okusaka, Takuji
    CHEMOTHERAPY, 2013, 59 (01) : 74 - 78
  • [10] ICER-IIγ is a tumor suppressor that mediates the antiproliferative activity of cAMP
    Reza Razavi
    Juan C Ramos
    Ghassan Yehia
    Florence Schlotter
    Carlos A Molina
    Oncogene, 1998, 17 : 3015 - 3019
12345